PATENT CLAIM ANALYSIS

Application Number: 16151113
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["514", "738000"]

Abstract:
The present invention provides compositions and methods of their use in treating muscular dystrophy and other disorders.

Claim (Index 4):
A method of treating or inhibiting the development of muscle weakness in a subject that is a carrier of a mutated FKRP gene or without defect in glycosylation of \u03b1-DG, comprising administering to the subject an effective amount of a ribose, thereby treating or inhibiting the development of muscle weakness.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.05882
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16151126', '15842580', '16112447', '16151137', '15880283']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8423163216725461
- 35 USC 102 Novelty (BERT): 0.6313350414107148
- Combined Prediction Score: 0.821218193646363
- Mean Citation Score: 586.107384
- Max Citation Score: 641.59375
- Similarity Product: 544.0374199822545

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test